Symptomatic treatment of brain metastases in renal cell carcinoma with sorafenib
Dongyan Hu, Yu Hu, Jisheng Li, Xiuwen WangJournal of Cancer Research and Therapeutics 2018 14(12):1223-1226
Brain metastasis is synchronous to the diagnosis of renal cell carcinoma (RCC). The prognosis of brain metastasis in RCC with the current treatment options is dismissal. Therefore, we present a case of an elderly female patient with RCC showing a partial response of brain metastasis after 18 months of 600 mg once daily sorafenib treatment who underwent right-sided nephrectomy. Further, withdrawal of sorafenib resulted in psychiatric changes along with increased metastasis lesions, which were recovered upon resuming the treatment, proposing that oral sorafenib can be used safely and efficiently for treatment of brain metastasis in advanced RCC.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Dongyan Hu Yu Hu Jisheng Li Xiuwen Wang Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Neurology | Oral Cancer | Psychiatry | Renal Cell Carcinoma